Authors: Karolína Doležalová Authors‘ workplace: Pediatrická klinika, 1. lékařská fakulta, Univerzita Karlova a Fakultní Thomayerova nemocnice, Praha Published in: Čes-slov Pediat 2025; 80 (4): 195-196. Category: doi: https://doi.org/10.55095/CSPediatrie2025/032
Doležalová K. advances in pediatric antituberculosis therapy: toward child-friendly all-in-one dosage forms
Contemporary pharmaceutical agents, specifically orodispersible tablets, are now entering the management of tuberculosis in children. The pharmaceuticals are available in two forms: either in combination (isoniaside+rifamp icin+pyrazinamide, isoniazid+rifampicin) or as monotherapy (isoniaside, ethambutol). the treatment is primarily indicated for the youngest age groups.
tuberculosis – treatment – oral dispersible all-in-one tablets
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
